Jump to content

କାବୋଜାଣ୍ଟିନିବ

ଉଇକିପିଡ଼ିଆ‌ରୁ
କାବୋଜାଣ୍ଟିନିବ
Clinical data
Pronunciationka" boe zan' ti nib[]
Trade namesCometriq, Cabometyx, others
SynonymsXL184, BMS907351
AHFS/Drugs.commonograph
MedlinePlusa613015
data
Pregnancy
category
Routes of
administration
By mouth
Legal status
Legal status
Pharmacokinetic data
Protein binding≥99.7%
MetabolismLiver (CYP3A4-mediated)
Elimination half-life110 hours
ExcretionFeces (54%), urine (27%)
Identifiers
  • N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
ECHA InfoCard100.221.147 Edit this at Wikidata
Chemical and physical data
FormulaC28H24FN3O5
Molar mass୫୦୧.୫୧ g·mol−1
3D model (JSmol)
  • O=C(C1(CC1)C(NC2=CC=C(F)C=C2)=O)NC(C=C3)=CC=C3OC4=C(C=C(OC)C(OC)=C5)C5=NC=C4
  • InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)
  • Key:ONIQOQHATWINJY-UHFFFAOYSA-N

କାବୋଜାଣ୍ଟିନିବ, ଅନ୍ୟମାନଙ୍କ ମଧ୍ୟରେ ବିକ୍ରୟ ନାମ କୋମେଟ୍ରିକ (Cometriq) ଏବଂ କାବୋମରଟିକ୍ସ (Cabometyx), ଏକ ଔଷଧ ଯାହା ମେଡୁଲାରୀ ଥାଇରଏଡ କର୍କଟ, ବୃକ୍‌କ କୋଷ କର୍କଟ ଏବଂ ହେପାଟୋସେଲୁଲାର୍ କର୍କଟ ରୋଗମାନଙ୍କର ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ । [] [୧୦] ଏହା ଉନ୍ନତ ରୋଗ କିମ୍ବା ଅନ୍ୟାନ୍ୟ ଚିକିତ୍ସାରେ ବିଫଳ ହୋଇଥିବା କ୍ଷେତ୍ରରେ ବ୍ୟବହୃତ ହୁଏ । [୧୧] ଏହା ପାଟିରେ ଦିଆଯାଏ | [୧୧]

ସାଧାରଣ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ତରଳ ଝାଡ଼ା, ଥକାପଣ, ଉଚ୍ଚ ରକ୍ତଚାପ, ବାନ୍ତି, ଏବଂ ଓଜନ ହ୍ରାସ ହୁଏ । [୧୦] ଅନ୍ୟାନ୍ୟ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ରକ୍ତସ୍ରାବ, ଫିଷ୍ଟୁଲା, ରକ୍ତ ଜମାଟ ବାନ୍ଧିବା, ଯକୃତ ସମସ୍ୟା ଏବଂ ରିଭର୍ସିବଲ୍ ପୋଷ୍ଟୋରିଅର୍ ଲ୍ୟୁକୋଏନସେଫାଲୋପାଥି ସିଣ୍ଡ୍ରୋମ ଅନ୍ତର୍ଭୁକ୍ତ ହୋଇପାରେ। [୧୧] ଗର୍ଭାବସ୍ଥାରେ ବ୍ୟବହାର ଶିଶୁର କ୍ଷତି କରିପାରେ । [୧୧] ଏହା ଏମଇଟ, (MET), ଭିଇଜିଏଫଆର (VEGFR), ଏବଂ ଏଏକ୍ସଏଲ (AXL)ମାନଙ୍କର ଟାଇରୋସିନ୍ କାଇନେଜ ଇନହିବିଟର । [୧୧]

୨୦୧୨ରେ ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଏବଂ ୨୦୧୪ରେ ୟୁରୋପରେ ଚିକିତ୍ସା ବ୍ୟବହାର ପାଇଁ କାବୋଜାଣ୍ଟିନିବ ଅନୁମୋଦିତ ହୋଇଥିଲା [][୧୦] ୨୦୨୧ରେ ଯୁକ୍ତରାଜ୍ୟରେ ୬୦ମିଗ୍ରା ଔଷଧର ଏକ ମାସର ମୂଲ୍ୟ ୫୧୫୦ ପାଉଣ୍ଡ ଥିଲା । [୧୨] ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଏହି ରାଶିର ମୂଲ୍ୟ ପ୍ରାୟ ୨୨,୬୦୦ ଡଲାର ଅଟେ । [୧୩]

  1. "Cabozantinib Use During Pregnancy". Drugs.com. 30 March 2020. Archived from the original on 3 December 2020. Retrieved 23 September 2020.
  2. "Cabozantinib". LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases. 2012. Archived from the original on 11 January 2022. Retrieved 29 December 2021.
  3. "Cometriq EPAR". European Medicines Agency (EMA). Archived from the original on 2 October 2018. Retrieved 23 September 2020.
  4. "Cabometyx EPAR". European Medicines Agency (EMA). Archived from the original on 4 August 2020. Retrieved 23 September 2020.
  5. "Cabozantinib tablet (Cabometyx) UK Summary of Product Characteristics". UK Electronic Medicines Compendium. September 2016. Archived from the original on 2019-06-23. Retrieved 2021-10-05.
  6. "Cabozantinib capsule (Cometriq) UK Summary of Product Characteristics (SPC) - (eMC)". UK Electronic Medicines Compendium. November 2016. Archived from the original on 2019-06-23. Retrieved 2021-10-05.
  7. "Cabometyx- cabozantinib tablet". DailyMed. 21 July 2020. Archived from the original on 29 October 2020. Retrieved 23 September 2020.
  8. "Cometriq- cabozantinib kit Cometriq- cabozantinib capsule". DailyMed. 11 February 2020. Archived from the original on 29 October 2020. Retrieved 23 September 2020.
  9. ୯.୦ ୯.୧ "Cometriq EPAR". European Medicines Agency (EMA). Archived from the original on 2 October 2018. Retrieved 23 September 2020.
  10. ୧୦.୦ ୧୦.୧ ୧୦.୨ "DailyMed - CABOMETYX- cabozantinib tablet". dailymed.nlm.nih.gov. Archived from the original on 29 October 2020. Retrieved 29 December 2021.
  11. ୧୧.୦ ୧୧.୧ ୧୧.୨ ୧୧.୩ ୧୧.୪ "DailyMed - CABOMETYX- cabozantinib tablet". dailymed.nlm.nih.gov. Archived from the original on 29 October 2020. Retrieved 29 December 2021.
  12. BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 1017. ISBN 978-0857114105.
  13. "Cabometyx Prices, Coupons & Patient Assistance Programs". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 4 March 2021. Retrieved 29 December 2021.